VQI study leader highlights virtue of multispecialty gathering of best longitudinal data on PAD procedures

1847

Daniel Bertges, MD, talks to Vascular Specialist about recent findings from his work investigating the IN.PACT Admiral drug-coated balloon (DCB). He related how they showed promising results in treating femoropopliteal in-stent restenosis in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. Speaking at Vascular Interventional Advances (VIVA) 2022 in Las Vegas (Oct. 31–Nov. 3), Bertges details the benefits of “so-called real-world data,” the “rich repository” of information contained within the VQI, and the virtues of the multispecialty nature of the registry.

LEAVE A REPLY

Please enter your comment!
Please enter your name here